MLL-ENL Inhibits Polycomb Repressive Complex 1 to Achieve Efficient Transformation of Hematopoietic Cells  by Maethner, Emanuel et al.
Cell Reports
ArticleMLL-ENL Inhibits Polycomb Repressive Complex 1
to Achieve Efficient Transformation
of Hematopoietic Cells
Emanuel Maethner,1 Maria-Paz Garcia-Cuellar,1 Constanze Breitinger,1 Sylvia Takacova,2,4 Vladimir Divoky,2
Jay L. Hess,3 and Robert K. Slany1,*
1Department of Genetics, University Erlangen, 91058 Erlangen, Germany
2Department of Biology, Faculty of Medicine and Dentistry, Palacky University, 77515 Olomouc, Czech Republic
3Department of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
4Present address: CEITEC-Central European Institute of Technology, Masaryk University, 62500 Brno, Czech Republic
*Correspondence: rslany@biologie.uni-erlangen.de
http://dx.doi.org/10.1016/j.celrep.2013.03.038SUMMARY
Stimulation of transcriptional elongation is a key
activity of leukemogenic MLL fusion proteins. Here,
we provide evidence that MLL-ENL also inhibits
Polycomb-mediated silencing as a prerequisite for
efficient transformation. Biochemical studies identi-
fied ENL as a scaffold that contacted the elongation
machinery as well as the Polycomb repressive com-
plex 1 (PRC1) component CBX8. These interactions
were mutually exclusive in vitro, corresponding to
an antagonistic behavior of MLL-ENL and CBX8
in vivo. CBX8 inhibited elongation in a specific re-
porter assay, and this effect was neutralized by direct
association with ENL. Correspondingly, CBX8-bind-
ing-defective MLL-ENL could not fully activate gene
loci necessary for transformation. Finally, we demon-
strate dimerization of MLL-ENL as a neomorphic
activity that may augment Polycomb inhibition and
transformation.INTRODUCTION
MLL fusions are highly efficient oncoproteins that transform
hematopoietic progenitors and cause aggressive leukemia
(Slany, 2009). These proteins are derived from chromosomal
translocations that affect the MLL locus at 11q23, joining an
N-terminal portion of the H3K4 histone methyltransferase MLL
with a variety of different partner proteins. These partner proteins
replace the original methyltransferase activity contained within
the MLL C terminus and create potent transactivators that cause
the inappropriate expression of target genes. Trithorax, the MLL
homolog in the fly, acts as a positive regulator of the clustered
Hox-homeobox genes. Analogously, MLL fusions induce a
strong overexpression of HOX, MEIS, and PBX homeobox
genes, with the latter two coding for HOX-binding partners.
Elevated levels of HOX/MEIS/PBX are sufficient to transform
hematopoietic progenitor cells, and deregulation of homeobox
genes is mainly responsible for the oncogenic activity of MLL
derivatives.CRemarkably, MLL chimeras generally do not behave as clas-
sical activators in recruiting RNA polymerase II (RNA PolII).
Depending on the fusion partner, they seem to either affect chro-
matin-associated processes or, more frequently, specifically
stimulate transcriptional elongation. MLL partners of the ENL
(ENL and AF9) and AFF (AFF1–AFF4) families form a higher-order
protein complex named EAP (originally standing for ENL-associ-
ated proteins and later for elongation-assisting proteins) that
was purified from nuclear extracts (Mueller et al., 2007, 2009).
In addition to ENL/AF9 and AFF proteins (AFF1 and AFF4 are
also known as AF4 and AF5q31 or short AF5), EAP also includes
positive transcription elongation factor b (P-TEFb) and the
H3K79 histone methyltransferase DOT1L. P-TEFb is a dimer of
CDK9 and a cyclinT that phosphorylates RNA PolII at serine-2
within the C-terminal repeat domain. Additional substrates
include proteins such as negative elongation factor (NELF) and
DRB sensitivity-inducing factor (DSIF), which help to keep RNA
PolII stalled shortly after initiation. Thesemodifications catalyzed
by P-TEFb are a crucial prerequisite for efficient elongation of
preinitiated transcripts (Peterlin and Price, 2006). DOT1L intro-
duces methylation of lysine-79 in histone H3, a modification
associated with actively transcribed chromatin. Interestingly,
DOT1L was first discovered in yeast, where H3K79 serves as
an ‘‘antisilencing’’ modification that inhibits invasion of hetero-
chromatin into transcribed areas (Nguyen and Zhang, 2011).
EAP-related complexes have been isolated by several labora-
tories (Bitoun et al., 2007; Monroe et al., 2011; Yokoyama
et al., 2010) and some studies suggest that EAP can be sepa-
rated into two subcomplexes with different functions. A super
elongation complex (SEC) stimulates elongation by recruiting
P-TEFb together with other elongation factors, and a separate
DOT1L-complex (DotCom) is responsible for chromatin modifi-
cation (reviewed in Smith et al., 2011). SEC may be widely
involved in transcriptional control because it has also been co-
purified with the HIV Tat protein, which is known to support viral
transcription by stimulating elongation (He et al., 2010; Sobhian
et al., 2010). Although EAP is unequivocally connected to active
transcription, paradoxically, proteins that are normally associ-
ated with Polycomb repressive complex 1 (PRC1) have been
repeatedly demonstrated to interact and copurify with EAP com-
ponents (Garcı´a-Cue´llar et al., 2001; Hemenway et al., 2001;
Monroe et al., 2011; Mueller et al., 2007).ell Reports 3, 1553–1566, May 30, 2013 ª2013 The Authors 1553
Originally, Polycomb proteins were identified in Drosophila as
opponents of trithorax function. The balance between trithorax-
mediated activation and repression by Polycomb dynamically
regulates the transcriptional output of many genes, particularly
those involved in self-renewal, differentiation, and develop-
mental decisions (HOX genes are a paradigmatic example).
Because trithorax as well as Polycomb activities involve chro-
matin modification, the corresponding marks become heritable
and constitute part of what has been termed ‘‘epigenetic mem-
ory.’’ In mammals, this function has been conserved (reviewed
in Margueron and Reinberg, 2011). Major representatives of
mammalian Polycomb proteins can be found in two different
protein complexes. Polycomb repressive complex 2 (PRC2) con-
tains the conserved histone methyltransferase EZH2 (enhancer
of zeste homolog 2), which introduces H3K27 di- and trimethyla-
tion, whereas PRC1 catalyzes histone H2A ubiquitination via the
RING1/2 E3 ligases. These enzymes are accompanied by a var-
iable set of associated factors that include PCGF (Polycomb
group ring finger), PHC (polyhomeotic homolog), and CBX (chro-
mobox) proteins (Gao et al., 2012). Chromobox proteins are
chromatin readers that recognize and bind to methylated
H3K27. Therefore, a sequential mechanism was suggested
whereby PRC2 deposits a repressive mark that is subsequently
read and interpreted by PRC1. However, PRC2-independent
recruitment of PRC1 has also been demonstrated (Dietrich
et al., 2012; Yu et al., 2012). Despite intensive studies, it is not
yet completely clear how PRC complexes actually repress.
Both chromatin compaction (Eskeland et al., 2010; Gao et al.,
2012) and inhibition of transcription by ubiquitinated H2A (Stock
et al., 2007; Zhou et al., 2008) seem to be involved.
Here we investigated the reason for the counterintuitive copur-
ification of PRC1 components with EAPs, and demonstrate that
Polycomb-mediated repression can be squelched by direct
interaction of the ENL and CBX8 proteins. Polycomb proteins
have been shown to colocalize with basal transcription factors
at loci ‘‘poised’’ for transcription (Oguro et al., 2010; Taberlay
et al., 2011), and it was speculated that PRC may block tran-
scription after the initiation step. This would mandate neutraliza-
tion of PRC function before efficient elongation can occur. We
describe a likely mechanism that can achieve this effect and
thus may serve as a potential therapeutic target in the context
of MLL fusion proteins.
RESULTS
ENL Binds to PRC1 through CBX8
The PRC1 components CBX8 and RING1 were copurified with
ENL in a previous study (Mueller et al., 2007). To confirm the
data from that study and identify the subtype of PRC1 that inter-
acts with ENL, we purified CBX8 and the accompanying protein
complex from HEK293 cells, the source of the original identifica-
tion of EAP (Figure 1). These cells were transduced with flag-
tagged CBX8, and CBX8 interacting proteins were isolated by
tandem immunoprecipitation (IP) of nuclear extracts using
sequential pull-down with flag- and CBX8-agarose. Nontrans-
duced HEK293 cells served as control. Mass spectrometry
identified all classical PRC1 components from eluted bands
as visualized by silver staining (Figures 1A and 1B). Consistent1554 Cell Reports 3, 1553–1566, May 30, 2013 ª2013 The Authorswith a recent study that classified PRC1 subtypes (Gao et al.,
2012), CBX8 occurred mainly in PRC1.2 and PRC1.4 (i.e., in
MEL18- and BMI1-containing PRCs). ENL was consistently
copurified with PRC1 in three independent experiments, albeit
in substoichiometric amounts. The interaction of ENL and
CBX8 could also be corroborated by standard IP (Figure 1C).
Anti-flag-precipitated material from fCBX8 expressing HEK293
cells contained immunologically detectable ENL and, vice
versa, CBX8 could be identified by western blot in fENL
precipitates.
Little is known about direct protein contacts within PRC1. To
determine how ENL would fit into this interaction network, we
identified PRC1 components that make a direct contact with
CBX8. Full-length versions of the major PRC proteins were
tested in a two-hybrid system, with CBX8 (Figure 1D) or various
CBX8 deletion mutants (Figure 1E) used as baits. Constructs
were correctly expressed in yeast (Figure 1F) and did not show
any endogenous transactivation (not shown). In addition to the
known interaction with ENL, direct binding of CBX8 was
observed with both RING proteins (RING1 and RING2) but not
with any of the other PRC1 components tested. Mapping of
the respective interaction domains revealed two separable re-
gions at the CBX8 C terminus that independently mediated bind-
ing to ENL and RING (Figure 1E). A small deletion of amino acids
335–340was sufficient to disrupt ENL interaction, but this did not
affect affinity for RING proteins. In summary, CBX8 can establish
a connection between ENL and PRC (Figure 1G).
CBX8 Can Bind ENL and RING Simultaneously, but ENL
Allows Only Mutually Exclusive Interactions
Because ENL and RING bind to CBX8 at closely neighbored
sites, we wanted to know whether these interactions can occur
at the same time. It was previously shown that all direct binding
partners of ENL (AF5/4 [AFF4/AFF1], DOT1L, and CBX8) contact
overlapping or immediately adjacent motifs in ENL (He et al.,
2011; Mueller et al., 2009). Therefore, it was not clear whether
CBX8 can interact with ENL once it is occupied by other EAP
components. To clarify these questions, we performed an elab-
orate set of IPs (Figure 2). Various combinations of differently
tagged proteins were coexpressed in 293T cells to test mutual
binding in the presence of a third protein competing for the
same binding site. For CBX8, a clear picture emerged indicating
that the individual interactions of CBX8 (Figure 2A) with ENL and
RING1 can occur simultaneously. CBX8 could bridge ENL with
RING, as suggested by coprecipitation of RING1 with ENL (Fig-
ure 2A, left panels) and vice versa (Figure 2A, middle panels) in
the presence of CBX8. CBX8 itself contacts both proteins (Fig-
ure 2A, right panels). In contrast, binding of ENL to its interaction
partners was only possible one at a time. Although an associa-
tion of CBX8 and Dot1l with ENL could be confirmed separately
(Figure 2B, right panels), ENL could not ‘‘bridge’’ the two pro-
teins, suggesting that these contacts are not coincident (Fig-
ure 2B, left and middle panels). A similar result was obtained
with AF5 (Figure 2C). Again, CBX8 and AF5 could associate
with ENL individually (Figure 2C right panels) but not simulta-
neously (Figure 2C, left and middle panels). In summary, these
results can be best reconciled with a scaffolding function of
ENL that allows only one contact at any given moment, thereby
Figure 1. Purification and Molecular Architecture of PRC1
(A) Silver-stained gel of a typical PRC1 preparation. Nuclear extracts from HEK293 cells transduced with a flag-tagged version of CBX8 were used for tandem IP,
as schematically indicated, and nontransduced cells served as controls. The gel is a typical example of three independent experiments.
(B) Mass spectrometric identification of CBX8 copurifying proteins. Not listed are heat shock proteins HSPA1, HSPA8, and HSPA9, whichwere also present in the
immunoprecipitates.
(C) Coprecipitation of CBX8 and ENL. Flag-reactive material was precipitated from nuclear extracts of HEK293 expressing either flag-CBX8 (upper panel) or flag-
ENL (lower panel). The presence of ENL and CBX8 was detected by western blotting. WT HEK293 lysates were used as controls.
(D) Typical example of a two-hybrid experiment screening for direct interactions between full-length CBX8 (bait) and PRC1 members (prey). Growth on control
and selective (histidine) plates is shown.
(E) Mapping of the ENL and RING interaction domains in CBX8. CBX8 constructs as indicated were tested as in (D). Growth on selective plates is indicated by +.
(F) Expression of GAL4 constructs used for two-hybrid experiments. Yeast lysates were analyzed by immunoblotting with anti-GAL4 AD antibodies (upper panel)
and anti-GAL4 DNA-binding domain reagents (lower panels).
(G) Schematic depiction of PRC1-EAP interactions.enforcing a sequential order of events. This agrees well with pre-
vious results showing that AF5 and DOT1L also exclude each
other in binding to ENL (Yokoyama et al., 2010).CPRC1 and MLL-ENL Induce Opposing Activities In Vivo
The in vitro results suggested the possibility that CBX8/PRC1
and ENL/EAP activities may influence each other. There is noell Reports 3, 1553–1566, May 30, 2013 ª2013 The Authors 1555
Figure 2. Analysis of Concurrent Protein Interactions
(A) Simultaneous binding of ENL and RING1 to CBX8. Tagged (f, flag; H, HA) and untagged versions of CBX8, ENL, and RING1 were cotransfected as indicated.
Proteins targeted for precipitation are marked in red font.
(B) Dot1l and CBX8 cannot bind simultaneously to ENL. No coprecipitation of Dot1l and CBX8 was observed (left and middle panels) despite the fact that ENL
binds to both proteins individually (right panels). Tags and proteins are labeled as in (A).
(C) Binding of AF5 (AFF4) and CBX8 to ENL is mutually exclusive. CBX8 could not precipitate AF5 in the presence of ENL (left, middle panels), yet ENL interacts
with both proteins in the same lysates (right panels). Labeling as in (A).direct biological assay for ENL activity in vivo. However, in the
context of an MLL fusion protein, ENL function reads out as
transformation capability. In order to investigate the biological
consequences of CBX8/PRC1-mediated repression for cellular
transformation, we overexpressed CBX8 in Mll-ENL immortal-
ized cells. Because artificially high concentrations of MLL-
ENL may skew the balance and therefore affect the outcome
of this experiment, we chose to use a recently published Mll-
ENL-ER knockin model (Meer mice; Takacova et al., 2012) for1556 Cell Reports 3, 1553–1566, May 30, 2013 ª2013 The Authorsthis test. In Meer animals, an inducible Mll-ENL fusion was
created in the germline by knockin of ENL joined to the
ligand-binding domain of the estrogen receptor. Therefore,
Mll-ENL-ER is expressed under control of the endogenous
Mll promoter (Figure 3A). Isolated bone marrow progenitors
from these mice can be immortalized by the simple addition
of tamoxifen, leading to the outgrowth of permanent cell lines.
To study the effect of elevated CBX8 on Mll-ENL-mediated
transformation, we transduced Meer cells with a pMSCV-based
expression construct for CBX8, which led to a large increase of
CBX8 RNA and protein as compared with vector-transduced
controls (Figure 3B). The Meer/CBX8 cells were viable and
could be propagated for several weeks in culture. In a quanti-
tative assessment by colony-forming cell (CFC) assays, how-
ever, they consistently showed a reduced replating capability
and formed fewer colonies in methylcellulose (Figure 3C).
Phenotypically, these cells displayed a higher level of the differ-
entiation marker Gr-1 on the surface, indicative of a weakened
transformation by Mll-ENL (Figure 3D). This was mirrored at
the molecular level by lower RNA concentrations of the key
Mll-ENL targets Hoxa9 and Meis1 (Figure 3E). In contrast to
CBX8, overexpression of RING1 elicited only minor effects in
Meer cells, indicating that CBX8, but not RING1, is a limiting
factor (Figure S1).
To study the molecular events occurring at the respective
genomic loci, we performed chromatin IP (ChIP) experiments
around the Hoxa9 and Meis1 transcriptional start sites (Figures
3F–3H). In cells with active Mll-ENL (+TAM) that overexpress
CBX8 (Figure 3F), we observed a drop of four different elonga-
tion markers corresponding to the reduced transcription of
Hoxa9 and Meis1. H3K79me2, H3K36me2, RNA PolII serine-2
phosphorylation, and ENL were moderately but consistently
reduced by 20%–50% compared with vector controls. Interest-
ingly, no significant increase of H2A ubiquitination as a readout
for PRC1 activity was observed in CBX8 cells as long as
tamoxifen was present (Figure 3G, left panel). H3K27 methyl-
ation as one potential recruiting element for CBX8 was equally
present in transduced and control cells (Figure 3G, right panel).
The observed reduction in Hoxa9 and Meis1 transcripts in
CBX8 cells was not due to decreased Mll-ENL binding,
because this parameter remained unchanged or was even
slightly increased after overexpression of CBX8 (Figure 3H,
left panel). Rather, the reduction in transcription was correlated
with a 2- to 3-fold increase in chromatin-bound CBX8 protein
(Figure 3H, right panel).
To investigate this phenomenon, we repeated the ChIP ex-
periments 72 hr after inactivation of Mll-ENL by removal of
tamoxifen. As was previously shown (Milne et al., 2005), this
led to cellular differentiation and paralleled an exit of Mll-ENL
from its target loci. As a consequence, elongation markers
were almost completely lost, with the exception of H3K36
dimethylation, which remained detectable at this time point
(Figure 3F). Remarkably, inactivation of Mll-ENL led to a large
increase of PRC1 and PRC2 activity exclusively in CBX8 cells,
whereas this effect was almost negligible in controls (Figure 3G).
This was not correlated with the levels of chromatin-bound
CBX8 (Figure 3H, right panel), because additional overexpres-
sion of CBX8 in differentiating Mll-ENL cells (TAM) even led
to a reduction of ChIP-detectable CBX8 bound to the locus.
In contrast, there was an inverse association with remaining
Mll-ENL (Figure 3H, left panel) that exited earlier from the
Hox/Meis loci in CBX8 cells compared with vector controls
and corresponding to the more advanced state of differentia-
tion in CBX8 cells. This suggests that Mll-ENL has to fall below
a certain threshold before PRC1 can become active, support-
ing a suppressive role of Mll-ENL in CBX8 and Polycomb
function.CCBX8 Bound by ENL Loses Repressor Activity in an
Elongation Reporter Assay
Because ENL and MLL-ENL mainly stimulate transcriptional
elongation, we wanted to assess the consequences of the
ENL/CBX8 interaction with respect to this parameter. Elongation
can be specifically measured with a specialized reporter assay
(Rev assay) that makes use of the fact that the HIV long terminal
repeat (LTR) is known to be controlled mostly after initiation has
occurred (Gold and Rice, 1998). A luciferase-based reporter sys-
tem (Figure 4A) driven by a modified HIV LTR contains an engi-
neered binding motif (SLIIb loop) for the RNA-binding protein
Rev. This loop is located within the short RNA that is produced
after RNA PolII initiates transcription. In this way, any protein of
interest can be recruited to the paused RNA polymerase, allow-
ing readout of either stimulating or repressive activity. A series of
Rev-CBX8 mutants, including deletions of the C-terminal RING-
binding domain and a CBX8 derivative without the ENL interac-
tion motif (CBX8D332-342), were constructed and tested for
correct expression (Figure 4B). Coimmunoprecipitation (Co-IP)
confirmed that the CBX8D332-342 mutant had lost the capacity
to bind ENL, whereas the interaction with RING was untouched
(Figure 4C). Both CBX8 and CBX8D332-342 demonstrated a
clear, concentration-dependent repressor activity in Rev assays
(Figure 4D, left panel). This indicates a CBX8 intrinsic inhibitory
function that does not require binding to ENL. Corroborating a
previous study (Grau et al., 2011), the CBX8-encoded repressor
function was not contingent on RING binding, as a loss of the
RING-binding domain in the CBX8_1-331 construct did not
affect its inhibitory activity (Figure 4D, right panel). Rather, the
repressor function relied on an extended, highly charged region
within the central portion of the protein. Small hairpin RNA
(shRNA) experiments were also consistent with a RING-indepen-
dent repressor activity for CBX8 (Figure S2).
Interestingly, CBX8-mediated repression was largely neutral-
ized by coexpression of ENL (Figure 4E). This phenomenon
was absolutely reliant on a direct ENL/CBX8 interaction,
because ENL-binding defective CBX8mutants remained repres-
sors even in the presence of ENL. In an attempt to confirm these
results in a reciprocal fashion, we constructed an ENL mutant
that has lost CBX8 affinity but keeps all other interactions intact.
Because DOT1L and CBX8 bind to coinciding regions in ENL, we
chose to test a point mutant that has been found to specifically
abrogate CBX8 binding in the homologous AF9 protein (Tan
et al., 2011). The corresponding T546A exchange was intro-
duced into ENL and correct protein expression was confirmed
by western blotting (Figure 4F). Interactions between Dot1l and
ENLT546A were unaffected, but affinity for CBX8 was no longer
detectable in co-IP experiments under stringent washing condi-
tions (Figure 4G). Interaction with AF5 also remained intact (Fig-
ure 4H). In contrast towild-type (WT)-ENL, ENLT546Awas signif-
icantly weaker in ‘‘rescuing’’ transcriptional elongation from
CBX8-mediated repression (Figure 4I). The remaining activity
of ENLT546A was likely due to residual binding to CBX8 that
was not completely abrogated by introduction of the single-point
mutation. A complete ablation of the ENL/CBX8 interaction by
using an ENL-binding defective CBX8 mutant (CBX8D332-342)
fully eliminated the ENLT546A-induced effect on CBX8-induced
repression (Figure 4J). Because ENLT546A retained someell Reports 3, 1553–1566, May 30, 2013 ª2013 The Authors 1557
Figure 3. Mutual Inhibition of MLL-ENL and PRC1 In Vivo
(A) Schematic depiction of the Mll-ENL-ER (Meer) knockin construct. Meer bone marrow progenitors can be immortalized by the simple addition of tamoxifen.
neo, neomycin resistance; pA, polyA sequence.
(B) Left panel: Detection of CBX8 overexpression by qRT-PCR. Meer cells were infected with either empty viruses or a viral expression construct for CBX8. qPCR
primers that amplify the mouse and human CBX8 sequence were chosen. Given are the means and SDs of a triplicate, and these data represent one out of three
experiments with similar outcome.
(legend continued on next page)
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affinity for CBX8, we tried to introduce an additional amino acid
exchange (T534A) that has been demonstrated to be important
for CBX8 binding in AF9. The introduction of the second muta-
tion, however, also reduced affinity for Dot1l (Figure S3), and
therefore this construct was not tested further.
MLL-ENL Interaction with CBX8 Is Required for Efficient
Transformation
To assess the in vivo consequences of interfering with CBX8
binding, we introduced the ENLT546A mutation into an MLL-
ENL context (Figure 5A). The single amino acid change did not
affect expression of the protein, yet this mutant blunted the
transforming capacity of the respectiveMLL-ENL fusion. Primary
hematopoietic progenitors transduced with MLL-ENLT546A
formed 70% fewer colonies than those transformed by the
WT counterpart (Figure 5B). In addition, these cells could not
be propagated in liquid culture for more than 2 weeks, and termi-
nal differentiation and proliferation arrest eventually prevailed
(not shown). Concomitantly with the weaker replating efficiency,
endogenous concentrations of Hoxa9 and Meis1 transcripts
were significantly lower in MLL-ENLT546A cells compared with
controls (Figure 5C). H3K79 dimethylation was reduced but
nevertheless present at Hoxa9 and Meis1 loci, confirming that
DOT1L can still interact with the MLL-ENLT546A mutant. H2A
ubiquitination was slightly to moderately increased in MLL-
ENLT546A cells, and H3K27 methylation was barely detectable
in this retroviral overexpression model (Figure 5D). These data
can best be reconciled with an inability of MLL-ENLT546A to
make the target gene loci sufficiently permissive for transcrip-
tion. This occurs despite the fact that retroviral transduction
leads to overexpression of the MLL fusion.
Global Knockdown of Cbx8 Blunts Transformation by
MLL-ENL
BecauseMLL-ENLmust overcome aCBX8 (PRC1)-induced bar-
rier to immortalize cells, we speculated that global reduction of
this protein might aid in transformation. To test this assumption,
Meer cells were transduced with an shRNA construct targeting
Cbx8 or with a control vector. After antibiotic selection, the cells
were screened for surface-marker expression and for gene
expression at two different time points. Concordant with our hy-
pothesis, knockdown of Cbx8 initially (11 days after transduc-Right panel: Immunological detection of CBX8/Cbx8 in extracts of Meer cells tr
endogenous mouse protein. Ten times more total protein was loaded per lane fo
(C) CBX8 overexpression reduces CFC capacity of Meer cells. Hematopoietic pr
virus. Replating assays were performed in the presence of tamoxifen. The upper
charts relative colony numbers as the average and SD of six independent exper
(D) CBX8 induces higher levels of the differentiation marker Gr-1 on the cell su
expression by fluorescence-activated cell sorting (FACS) analysis. The percenta
(E) CBX8 overexpression reduces Hoxa9 and Meis1 expression in Meer cells. Q-
indicated. Averages and SDs of a technical triplicate are given, representing a ty
(F) ChIP for elongation associated chromatin modifications and marker proteins.
bars). ChIP for modifications and factors was done as indicated. Experiments w
tamoxifen was removed (light bars, TAM). Precipitation is given as% input. Uns
illustrates averages and SDs of PCR triplicates. The ChIP experiment was done
(G) Detection of Polycomb-associated chromatin modifications. ChIP was perfo
(H) Presence of CBX8 and Mll-ENL as detected by ChIP.
See also Figure S1.
Ction) caused a shift toward cells with lower Gr-1 levels, indicating
a stronger block in differentiation. However, this phenomenon
was short-lived and the knockdown effect was lost after further
culture (Figure 6A). This transient phenotype was correlated
with a rebound of Cbx8 from 50% suppression at day 11 to
nearly normal levels at day 19 (Figure 6B), indicating outgrowth
of cells that have lost shRNA expression. A potential reason for
this observation became apparent when we checked the tran-
scripts of the Cdkn2 (Ink4) tumor suppressor family (Cdkn2a,
Cdkn2b, Cdkn2c, and Cdkn2d), which are known PRC1 targets.
In line with previous findings (Dietrich et al., 2007), knockdown of
Cbx8 was inversely correlated to the concentrations of Cdkn2a
and Cdkn2b, two powerful inhibitors of cell-cycle progression
that are transcribed from the same locus. Concordant and in par-
allel with the surge in Cdkn2a/b transcription, a pronounced but
transient G1 arrest was observed in Cbx8 knockdown cells (Fig-
ure 6C). This phenomenon was correlated to a reduced plating
efficiency of the respective cells in methylcellulose (Figure 6D).
Thus, derepression of the Cdkn2a/b genes is a likely explanation
for the growth disadvantage of cells with globally reduced Cbx8
concentrations.
MLL-ENL Can Dimerize to Allow the Simultaneous
Occurrence of Normally Separated Processes
The Co-IP results and the mutational analysis suggested that
under normal circumstances, binding of CBX8 and DOT1L/P-
TEFb to ENL cannot occur simultaneously. This presumably al-
lows for regulation and may control the extent of transcriptional
stimulation. Nevertheless, genes activated by MLL fusion pro-
teins are at the same time hypermethylated at H3K79 (Krivtsov
et al., 2008), highly transcribed, and not blocked by PRC1. This
suggests that ENL may circumvent normal control mechanisms
in the context of the fusion. To investigate the molecular basis of
this effect, we probed for dimerization of MLL-ENL because this
would allow for recruitment of elongation factors despite the
presence of CBX8 (PRC1). In addition, it is known that fusions
of MLL with strong dimerization domains are weakly transform-
ing (Martin et al., 2003; Xia et al., 2003). To check for self-asso-
ciation of MLL-ENL, we coexpressed flag- and hemagglutinin
(HA)-tagged versions of this protein. Precipitation with a flag-
specific antibody (Figure 7A, left panels) clearly brought down
HA-tagged MLL-ENL. This was not due to an unspecificansduced as before. Epitope-tagged human CBX8 is 7 kDa larger than the
r the vector control.
ogenitor cells from Meer bone marrow were transduced with CBX8 or control
panel shows a representative example of third-round colonies; the bar graph
iments.
rface. Meer cells from the experiments shown in (C) were analyzed for Gr-1
ge of Gr-1 positive cells was calculated using the indicated region.
RT PCR was performed on total RNA isolated from Meer cells transduced as
pical example out of three experiments in total.
Meer progenitor cells were transduced with vector (gray bars) or CBX8 (green
ere performed in the presence of tamoxifen (dark bars, +TAM) and 72 hr after
pecific immunoglobulin G (IgG) served as control (red hatched bars). The chart
on three biological replicates with essentially the same results.
rmed as described in (F).
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Figure 4. In Vitro Inhibition of Transcriptional Elongation by CBX8 Is Blocked by Direct Contact with ENL
(A) Schematic description of the Rev elongation reporter system. A modified HIV LTR drives a luciferase reporter gene. The Tat-interacting TARmessenger RNA
(mRNA) loop is modified to contain an SLIIb recognition site for the RNA-binding protein Rev. Rev-fusion proteins are directed to the RNA-bound, ‘‘stalled’’ RNA
PolII. In this way, any influence on elongation can be specifically read out by alterations of luciferase activity.
(B) CBX8 mutants tested in Rev assays. Left panel: Representation of various C-terminal CBX8 deletions. The N-terminal chromobox (chro) and the central
charged region (+, ), as well as the ENL and RING binding domains are labeled. Right panel: anti-Rev western blot of Rev-CBX8 derivatives.
(C) An 11 amino acid deletion in CBX8 selectively abrogates ENL binding. CBX8 and a CBX8 mutant missing amino acids 332–342 were tested in Co-IP for their
interaction with ENL (upper panel) and RING1 (lower panel).
(D) Repression of transcriptional elongation by CBX8 is independent of ENL and RING and relies on a charged region. Increasing amounts of Rev-CBX8 and Rev-
CBX8D332-342 constructs were cotransfected together with elongation reporter into 293T cells (left panel). To determine the repressor domain in CBX8, a series
of C-terminal deletion mutants was tested in the same assay (right panel).
(legend continued on next page)
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association with DNA, as all extracts were extensively digested
with benzonase to remove interfering nucleic acids. Unexpect-
edly, dimerization was not contingent on the ENL fusion partner.
The amino-terminal MLL moiety up to the fusion point at amino
acid 1444 could replace full-length MLL-ENL as the precipitating
agent without loss of efficiency (Figure 7A, right panels). A
deletion analysis identified two regions within MLL that were
responsible for dimer formation. The first self-association
domain coincided with the AT-hook motif at the very MLL N
terminus (Figure 7B) and the second comprised the CxxC
domain further C-terminal (Figure 7C). Remarkably, both
domains could also heterodimerize (Figure 7D). Homo- and het-
erodimerization capabilities could be separated. N-terminal por-
tions were necessary for homodimerization of the AT-hook and
the CxxC motif, whereas the C-terminal parts of the respective
peptides were sufficient for heterologous interaction (Figure S4).
Homo- and heterodimer formation could also be demonstrated
by glutathione S-transferase (GST) pull-down (Figure S4). Puri-
fiedGST fusions of the AT-hook andCxxC peptides efficiently in-
teracted with their tagged counterparts in nuclear extracts.
Dimerization of MLL-ENL with WT-MLL was not possible under
identical conditions (Figure 7E). WT-MLL is posttranslationally
processed and forms a dimer of the respective MLLN and
MLLC moieties. In cells coexpressing untagged WT-MLL
(= MLLN and MLLC after processing within the cell) and flag-
tagged MLL-ENL, IP with an antibody that binds to MLLN
brought down the MLLN-interacting MLLC (Figure 7E, lower
panel). In contrast, the same procedure done with anti-flag
precipitated only flagMLL-ENL (Figure 7E, middle panel), and
not MLLC (Figure 7E, upper panel), indicating that the fusion pro-
tein does not interact with the MLLN/MLLC dimer.
In contrast to monomeric ENL, the MLL-ENL fusion was able
to connect CBX8 with both Dot1l and AF5 in precipitation as-
says. This is in line with a capability for di-/multimer formation
that is unique to theMLL fusion protein and is absent in ENL (Fig-
ures 7F and 7G).
DISCUSSION
The balance between trithorax/MLL and Polycomb activity is an
important factor in determining the output of a transcriptional
unit. Here we reveal another aspect of this ‘‘ying-yang’’ relation-
ship and provide evidence that stimulation of transcription by the
EAP activator complex and Polycomb-mediated repression are(E) Direct interaction with ENL neutralizes the CBX8-induced repression of elo
CBX8_1-331 deleting both ENL and RING1 interaction domains were cotransfecte
as before.
(F) A point mutation that had been shown to disable interaction of the ENL homolog
of ENL, where binding sites for Dot1l and CBX8 overlap.
(G) The ENLT546A mutant abrogates CBX8 binding but leaves interaction with Do
with Dot1l and CBX8. Precipitation of ENL indicated that the interaction with Do
(H) Co-IP of WT-ENL and ENLT546A with AF5. Similar affinities of WT-ENL and
experiments.
(I) ENLT546A does not efficiently rescue CBX8-mediated repression. ENL, ENL
reporter. Whereas some activity remains for ENLT546A, this mutant is significan
(p values were calculated by Student’s t test, n = 3).
(J) Combining ENLT546A with the CBX8D332-342 mutant completely abolishes
See also Figures S2 and S3.
Crival activities, with ENL and CBX8 as key regulators. Inhibition
of PRC1 adds yet another function to the repertoire ofMLL fusion
proteins, contributing to their potent transforming potential,
and explains the consistent copurification of repressor proteins
with ENL.
Because Polycomb complexes encode enzymatic activities
that may be potentially ‘‘druggable,’’ the role of PRCs in hemato-
logical malignancies, and cancer in general, is of great interest.
With respect to MLL fusions, two recent studies showed that
global reduction of PRC2 function by conditional knockout of
essential components impaired MLL-AF9-induced leukemogen-
esis in vivo (Neff et al., 2012; Tanaka et al., 2012). Loss of PRC2
led to a widespread derepression of genes involved in cell-cycle
control and differentiation. This included known tumor suppres-
sors (e.g., Cdkn2a) as well as genes that induce maturation (e.g.,
Egr1). In addition, a transformation-associated Myc-gene
expression module was suppressed in PRC2 knockout cells.
These findings are consistent with our results after general
knockdown of Cbx8, and similar observations have also been
made in solid tumors. In normal cells, CBX8 bypasses senes-
cence by binding directly to the INK4A-ARF region (Dietrich
et al., 2007). In general, derepression of tumor suppressors is
the rationale for clinical attempts to use EZH2 inhibitors as ther-
apeutics. However, it has been known for a long time that the
oncogenic HOX loci are also under Polycomb control, and here
we show that inhibition of Polycomb-mediated repression con-
tributes to transformation in MLL-fusion-induced leukemia.
Therefore, the situation in malignant disease is more complex,
and artificial interference with repressor activities may have
unwanted side effects that could even exacerbate oncogene
activity. Reflecting this dualism, it seems logical that EZH2muta-
tions in hematological malignancies may either enhance or
destroy catalytic activity depending on whether tumor suppres-
sors or oncogenes play the major role in the transformation
process (Hock, 2012). With respect to novel treatments for
MLL-induced leukemia, it would seem more advisable to target
the interaction of MLL fusions with CBX8 directly than attempt
to inhibit global PRC activity. In particular, patient cells that
have lost the CDKN2 tumor suppressor locus, which occurs
frequently in leukemia (Sulong et al., 2009), may respond unex-
pectedly to such a generalized epigenetic therapy.
Interestingly, MLL fusion proteins have evolved different stra-
tegies to overcome Polycomb-induced repression. A recent
report (Tan et al., 2011) showed that MLL-AF9 evokes angation. CBX8, CBX8D332-342 (ENL binding site deletion), and a truncated
d together with reporter and an expression construct for ENL or a vector control
AF9 with CBX8was introduced at the corresponding residue at the C terminus
t1l intact. ENL, ENLT546A, and a vector-only control were expressed together
t1l is unharmed, whereas CBX8 association is abrogated in ENLT546A.
the CBX8 binding-defective point mutant ENLT546A were observed in these
T546A, or a vector control were cotransfected with CBX8 and the elongation
tly weaker than WT-ENL in rescuing CBX8-mediated repression of elongation
any effect of ENL on CBX8-induced repression.
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Figure 5. MLL-ENL Needs Interaction with CBX8 for Efficient
Transformation
(A) Graphical representation and expression of the MLL-ENL construct con-
taining the T546A mutation in the ENL portion. WT and MLL-ENLT546A were
expressed at equal levels in Phoenix packaging cells (*, unspecific band).
(B) Reduced CFC capability of MLL-ENLT546A-transformed cells. Upper
panel: Representative example of third-round colonies formed by progenitors
transduced byMLL-ENL orMLL-ENLT546A viruses as indicated. Lower panel:
Aggregated results (average and SD) of three biological replicates.
(C) Expression of Hoxa9 and Meis1 in MLL-ENLT546A-transduced cells is
reduced. qRT-PCR was done on RNA isolated from cells after two rounds of
replating.
(D) Histone patterns are shifted toward repression in MLL-ENLT546A cells.
Chromatin was isolated from cells transduced with either MLL-ENL or MLL-
ENLT546A after two rounds of replating and subjected to ChIP as indicated.
Enrichment is given as % input. Bars depict the average and SD of a PCR
triplicate, and this experiment was done twice with essentially the same result.
1562 Cell Reports 3, 1553–1566, May 30, 2013 ª2013 The Authors‘‘moonlighting’’ function in CBX8 by using it as an intermediate to
recruit the histone acetylase TIP60. In this way, MLL-AF9
induced local histone acetylation that was associated with
HOX expression and transformation. Our results suggest that
MLL-ENL works differently, because we could not find any evi-
dence for an interaction of ENL or CBX8 with TIP60 either by
biochemical purification or in direct co-IP attempts (not shown).
This is not without precedent, because although ENL and AF9
are homologs, they are not identical. For example, ENL copuri-
fies with CDK9/CYCT2 (Mueller et al., 2007), whereas AF9 asso-
ciates with the alternative CDK9/CYCT1 conformation of P-TEFb
(Monroe et al., 2011).
Unfortunately, not much is known about the molecular details
of Polycomb-mediated repression. It would be tempting to
speculate that part of the repressor activity of CBX8 may be
due to its interfering with ENL function by physically displacing
other ENL-bound factors. The structural basis for mutually exclu-
sive binding was explored in a recent study of AF9 (Leach et al.,
2012). Interaction of AF9 with various proteins is mediated by an
intrinsically disordered domain that adopts different conforma-
tions depending on the respective binding partner, thereby re-
stricting interaction to a single protein at any time. However,
competition cannot be the sole reason for repression by CBX8,
because CBX8 without an ENL-binding domain still acts as a
repressor. Therefore, an alternative mechanism(s) must exist.
An attractive possibility, as described in a previous study (Grau
et al., 2011), is chromatin compaction that can occur in vitro
and in vivo. This process has been demonstrated to be a prere-
quisite for silencing at HOX loci (Eskeland et al., 2010). Compac-
tion is independent of histone modification and can be induced
by various Polycomb group proteins that carry highly charged re-
gions, such as those present within the central portion of CBX8.
In this respect, it is interesting to note that a feature ofCBX8, a 16-
fold repeat of a dipeptide with alternating charge (DR/ER repeat),
is also present in NELF-E. NELF-E is responsible for stalling RNA
PolII by binding to nascent RNA, and this block is released by
phosphorylation through P-TEFb (Gilchrist et al., 2012).
Finally, we provide further support for a potential role of
dimerization in transformation, a feature that has been observed
for many oncoproteins (So and Cleary, 2004). ENL complexes
also control transcription in normal cells, and the sequential or-
der of events that is enforced by mutually exclusive binding of
the ENL interaction partners would be a perfect opportunity for
regulation of this process. The high transcriptional output seen
at MLL-ENL-controlled loci in leukemic cells suggests a bypass
of this mechanism. This could be achieved by dimerization that
allows multiple simultaneous interactions. The ability to dimerize
seems to be restricted to the fusion proteins, as MLL-ENL did
not interact with WT-MLL. Unfortunately, at present, the exact
importance of dimerization for MLL-ENL-mediated transforma-
tion cannot be experimentally tested because the regions in
the CxxC domain that mediate self-association are also respon-
sible for binding to the Polymerase-associated factor (PAF)
complex, a necessary cofactor for all MLL-fusion proteins (Milne
et al., 2010; Muntean et al., 2010). In this regard, it is important to
mention that the add-on of a strong dimerization motif alone is
sufficient to convert theMLLN terminus to aweakly transforming
protein. This was shown experimentally (Martin et al., 2003; Xia
Figure 6. Global Knockdown of Cbx8 Is
Incompatible with Transformation by MLL-
ENL
(A) Surface Gr-1 marker expression on Meer cells
transduced with a control vector or an shRNA
plasmid targeting Cbx8. Shown are overlay FACS
plots of cell populations after 11 days and 19 days
of selective culture, and the percentage of Gr-1
positive cells.
(B) Knockdown of Cbx8 induces tumor suppressor
genes. RNA was harvested from control and Cbx8
knockdown cells at 11 days and 19 days of culture
as indicated. Expression of Cbx8 and the Cdkn2
family was determined by qRT-PCR. The inset
shows a Cbx8-specific immunoblot.
(C) Cell-cycle analysis of Cbx8 knockdown cells.
Meer cells containing a Cbx8 shRNA (blue line) or
vector-only cells (black line) were analyzed for the
cell-cycle phase by propidium iodide (PI) staining
11 days and 19 days after transduction.
(D) Numerical evaluation of CFC assays performed
at early (11 days) and late (19 days) passage. Cells
were plated in triplicates into cytokine-supple-
mented methocel at the indicated time points and
colonies were enumerated 4–5 days later.et al., 2003) and suggested by the numerous rare translocation
partners that encode for cytoplasmatic proteins with dimeriza-
tion domains. Dimerizing MLL fusions would circumvent normal
control circuits and recruit more PAF complex. PAF, in turn, inter-
acts with SEC and therefore ENL (He et al., 2011). It is tempting
to speculate that fusion partners either increase intrinsic dimer-Cell Reports 3, 1553–156ization to offset the indirect ENL interac-
tion or provide direct access to ENL/
SEC, which makes endogenous dimer-
ization suffice.
EXPERIMENTAL PROCEDURES
Plasmids, Cell Culture, Animals, and
Antibodies
The complementary DNAs (cDNAs) used for
cloning are listed in Extended Experimental
Procedures. Retroviral packaging was done in
the Phoenix-E packaging line (Swift et al., 2001).
Protein expression and precipitation were per-
formed in 293T cells. Primary hematopoietic
progenitors were isolated from Meer mice that
carry a knockin of an inducible ENL-ER fusion
that is joined to genomic Mll sequences, reconsti-
tuting an Mll-ENL protein analogous to human
leukemia-derived samples. For a complete
description of the Meer model, see Takacova
et al. (2012). The culture conditions for the Meer
cells are described in Extended Experimental
Procedures.
Purification of PRC1
PRC1 was purified by tandem affinity precipitation
of tagged CBX8 essentially as described previ-
ously for EAP (Mueller et al., 2007). In short,
HEK293 cells were stably transduced with a flag-
CBX8 construct. Nuclear extracts from these cellswere precipitated with immobilized flag-agarose, bound material was eluted
by addition of flag-peptide, and a second precipitation was done with anti-
CBX8 agarose. Final precipitates were eluted by acid treatment (100 mM
glycine, pH 2.9) and analyzed by gel chromatography, silver staining, and
mass spectrometry. Similarly treated extracts from nontransduced HEK293
cells served as controls. Purification was done on three independent biological
samples.6, May 30, 2013 ª2013 The Authors 1563
Figure 7. Dimerization of MLL-ENL
(A) MLL-ENL dimerizes through the N-terminal MLL moiety. Flag-tagged and HA-tagged MLL-ENL as depicted were coexpressed and nuclear extracts were
precipitatedwith anti-flag agarose (left panels). Dimerization was not dependent on the ENL fusion partner as an N-terminal MLLmoiety (amino acids 1–1444) was
sufficient to induce self-association (right panels). f, flag; ME, MLL-ENL; numbers in subscript indicate the last amino acid of C-terminal deletion mutants. The
protein/peptide targeted for precipitation is labeled in red font.
(B) The AT-hook motif dimerizes. co-IP was done as in (A) with two differently tagged N-terminal subregions of MLL comprising amino acids 1–331. Note that IgG
heavy chain is detected at 50 kDa.
(C) The CxxC domain contains a second dimerization domain. Amino acids 1146–1337 of MLL containing the CxxC core and flanking regions were differentially
tagged and coprecipitation was done as above.
(D) The AT-hooks and CxxC domain heterodimerize. co-IP was done with AT-hooks and either a CxxC peptide as in (C) or a fragment thereof (amino acids 1146–
1252) containing only the core CxxC motif and a downstream basic region.
(E) MLL-ENL does not dimerize with WT-MLL. Flag-tagged MLL-ENL was coexpressed together with WT-MLL or empty vector as control. Full-length MLL was
subjected to natural posttranslational processing, yielding a stable dimer of MLLN (300 kDa) and MLLC (180 kDa) fragments. The MLLC product can be detected
with specific antibodies. anti-flag antibodies brought down substantial amounts of MLL-ENL but noMLLC (upper andmiddle panels), whereas antibodies against
MLLN that recognize WT-MLL as well as MLL-ENL successfully coprecipitated MLLC under the same conditions.
(F) Dimerization of MLL-ENL allows for simultaneous binding of CBX8 and Dot1l. CBX8, Dot1l, and either ENL or MLL-ENL were coexpressed and precipitation
was done with a CBX8-specific antibody.
(G) MLL-ENL bridges CBX8 to AF5. The experiment was done as in (F), probing for co-IP of CBX8 and AF5 in the presence of ENL or MLL-ENL.
See also Figure S4.Interaction Studies: Two-Hybrid, Co-IP, and GST Pull-Down
Two-hybrid analysis was performed according to standard procedures exactly
as described previously (Garcia-Cuellar et al., 2009).1564 Cell Reports 3, 1553–1566, May 30, 2013 ª2013 The AuthorsFor Co-IP studies, tagged and native versions of the proteins were ex-
pressed in 293T cells. Both EAP and PRC1 are endogenously present in these
cells, and therefore normal interactions should be able to form. When
subregions of proteins without an endogenous nuclear localization sequence
were used, a bona fide nuclear localization signal was fused to the N terminus.
The detailed procedures for IP and GST pulldown can be found in Extended
Experimental Procedures.
ChIP and Quantitative PCR
ChIP was performed with formaldehyde crosslinking according to a standard
protocol (Milne et al., 2009), with the modification that magnetic protein
G beads (Diagenode, Liege, Belgium) were used instead of agarose-coupled
protein G. Evaluation of ChIP was done by quantitative PCR (qPCR) in tech-
nical triplicates on at least two different biological samples. The primers
used for qPCR of ChIP precipitates were designed to amplify a region imme-
diately downstream of the respective transcription start sites, and they are
listed in Extended Experimental Procedures together with the antibody
sources.
Rev-Elongation Assays
Elongation was quantified by a special reporter system developed by Gold and
Rice (1998). In brief, this reporter uses a modified HIV LTR that has been engi-
neered to contain the sequence of the SLIIb stem-loop Rev-binding structure.
Proteins of interest can be recruited through a fusionwith Rev to RNA, and thus
are brought into the vicinity of an RNA polymerase stalling at the known LTR
pause point. Influence on elongation will read out as luciferase activity.
Because the elongation machinery is universally expressed, experiments
were done in 293T cells.
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